A.R.T. Advisors’s Cellectis CLLS Stock Holding History

A.R.T. Advisors’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-22,172	Closed	-$231K	–	1384
2019 Q3	$231K	Buy	22,172 +11,200	+102%	+$151K	0.01%	1146
2019 Q2	$171K	Buy	+10,972	New	+$196K	0.01%	1129
2018 Q3	–	Sell	-7,496	Closed	-$212K	–	1433
2018 Q2	$212K	Sell	7,496 -17,863	-70%	-$532K	0.01%	1214
2018 Q1	$799K	Buy	+25,359	New	+$801K	0.03%	746
2016 Q3	–	Sell	-13,365	Closed	-$355K	–	725
2016 Q2	$355K	Sell	13,365 -4,600	-26%	-$135K	0.02%	909
2016 Q1	$494K	Sell	17,965 -29,400	-62%	-$708K	0.02%	862
2015 Q4	$1.47M	Buy	47,365 +34,600	+271%	+$1.05M	0.07%	397
2015 Q3	$336K	Buy	12,765 +5,572	+77%	+$187K	0.01%	1011
2015 Q2	$259K	Buy	+7,193	New	+$252K	0.01%	1223

Other funds holding CLLS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

A.R.T. Advisors's CLLS Position: Q4 2019 in Review

A.R.T. Advisors sold out of Cellectis (CLLS) in Q4 2019, closing a stake of 22,172 shares — an estimated $231K sold.

A.R.T. Advisors first reported a position in CLLS in Q2 2015 and held it in 9 quarters. The position peaked at $1.47M in Q4 2015. 60 funds tracked by Wall St. Rank hold CLLS as of Q4 2019.

A.R.T. Advisors reported no remaining Cellectis position as of Q4 2019 after selling out during the quarter.
A.R.T. Advisors sold 22,172 Cellectis shares in Q4 2019, an estimated $231K.
A.R.T. Advisors first reported a position in Cellectis in Q2 2015 and held it in 9 quarters.
A.R.T. Advisors's Cellectis position peaked at $1.47M in Q4 2015.
60 funds tracked by Wall St. Rank held Cellectis as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.